Workflow
Globenewswire
icon
Search documents
Eisai Initiated Rolling Supplemental Biologics License Application to the U.S. FDA for LEQEMBI® IQLIK™ (lecanemab-irmb) as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer’s Disease Under Fast Track Status
Globenewswire· 2025-09-02 23:30
Core Insights - Eisai and Biogen announced the initiation of the rolling submission of the Supplemental Biologics License Application (sBLA) for LEQEMBI IQLIK, a subcutaneous autoinjector for lecanemab, which would be the first anti-amyloid treatment allowing at-home injection for Alzheimer's disease patients [1][2][28] - LEQEMBI is indicated for treating Alzheimer's disease in patients with Mild Cognitive Impairment (MCI) or mild dementia, and the sBLA is based on Phase 3 clinical study data [2][6][28] - The FDA granted Fast Track Status to LEQEMBI IQLIK, which could provide patients with a weekly starting dose option, enhancing treatment accessibility and reducing healthcare resource utilization [1][2][3] Company Overview - Eisai serves as the lead for the global development and regulatory submissions of lecanemab, with co-commercialization responsibilities shared with Biogen [4][32] - Lecanemab has been approved in 48 countries and is under regulatory review in 10 additional countries, indicating a strong international presence [3][28] - The collaboration between Eisai and Biogen for Alzheimer's treatments has been ongoing since 2014, focusing on joint development and commercialization [32] Product Details - LEQEMBI targets both amyloid plaque and protofibrils, which are believed to contribute to cognitive decline in Alzheimer's disease [3][5] - The subcutaneous formulation of LEQEMBI is designed to streamline the treatment pathway for Alzheimer's patients, allowing for home administration and potentially reducing the need for intravenous (IV) dosing [2][3] - The current injection time for the LEQEMBI IQLIK autoinjector is approximately 15 seconds, making it a convenient option for patients [2] Clinical Data - The sBLA for LEQEMBI IQLIK is based on evaluations from the Phase 3 Clarity AD open-label extension study, which followed an 18-month core study [2] - The treatment is expected to provide a choice between IV and subcutaneous administration, enhancing patient and caregiver flexibility [2] - The safety profile of LEQEMBI IQLIK for maintenance treatment is reported to be similar to that of the intravenous formulation [26]
Fortis Inc. Announces Pricing of Fixed-to-Fixed Rate Subordinated Notes
Globenewswire· 2025-09-02 23:06
Core Points - Fortis Inc. has announced a private placement offering of $750 million in 5.100% fixed-to-fixed rate subordinated notes due December 4, 2055 [1] - The offering is being conducted through a syndicate of agents and is expected to close on September 4, 2025 [1][2] - The net proceeds from the offering will be used to reduce borrowings under the corporation's revolving corporate credit facility and for general corporate purposes [2] - Fortis reported 2024 revenue of $12 billion and total assets of $73 billion as of June 30, 2025 [4] - The corporation serves utility customers across five Canadian provinces, ten U.S. states, and the Caribbean with a workforce of 9,700 employees [4]
Evolution Petroleum Schedules Fiscal Year End 2025 Earnings Release and Conference Call
Globenewswire· 2025-09-02 22:24
HOUSTON, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Evolution Petroleum Corporation (NYSE American: EPM) ("Evolution" or the "Company") today announced that it plans to release its fourth quarter and fiscal year-end 2025 financial and operating results on Tuesday, September 16, 2025, after the market closes. Additionally, Kelly Loyd, President and Chief Executive Officer, Ryan Stash, Senior Vice President, Chief Financial Officer, and Treasurer, and Mark Bunch, Chief Operating Officer, will review the results on a ...
California Water Service Increases Rebates on Water-Efficient Devices to Encourage Customers to Save Water Every Day
Globenewswire· 2025-09-02 21:45
Core Insights - California Water Service (Cal Water) has increased the value of conservation rebates to encourage customers to save water [1] - The company offers rebates on various indoor and outdoor conservation-related products, including high-efficiency clothes washers and low-water-use landscaping [1][4] - The CEO emphasizes the company's commitment to providing value to customers while being a responsible steward of natural resources [3] Rebate Details - Residential high-efficiency toilets now have rebates up to $150 [4] - Residential high-efficiency clothes washers now have rebates up to $500 [4] - Residential lawn-to-garden conversions offer rebates up to $5 per square foot [4] - Commercial high-efficiency toilets now have rebates up to $200 [4] - Commercial high-efficiency urinals now have rebates up to $300 [4] - Commercial lawn-to-garden conversions offer rebates up to $3 per square foot [4] Company Overview - California Water Service provides water utility services to over 2.1 million people through 499,400 service connections [3] - The company focuses on enhancing the quality of life for customers and communities by investing in water and wastewater infrastructure and sustainability initiatives [3] - Cal Water has been recognized as one of "America's Most Responsible Companies" and one of the "World's Most Trustworthy Companies" by Newsweek [3]
CEA Industries (BNC) Appoints Seasoned Global Investments Leader, Dr. Russell Read, as Non-Executive Director
Globenewswire· 2025-09-02 21:30
New York, Sept. 02, 2025 (GLOBE NEWSWIRE) -- CEA Industries Inc. (Nasdaq: BNC), (“BNC” or “the Company”), a growth-oriented company focused on managing the world’s largest corporate treasury of BNB, today announced the appointment of Dr. Russell Read, Ph.D., CFA, as a Non-Executive Director of the Company, effective immediately. Dr. Read brings more than three decades of global investment leadership and governance experience across sovereign wealth funds, pension systems, private investment firms, and finan ...
Dorchester Minerals, L.P. Announces Acquisition of Mineral Interests
Globenewswire· 2025-09-02 21:16
Company Overview - Dorchester Minerals, L.P. is based in Dallas and owns producing and non-producing oil and natural gas mineral interests across 28 states [2] Recent Acquisition - The company announced the completion of an acquisition of mineral interests totaling approximately 3,050 net royalty acres located in Adams County, Colorado [1] - The transaction was structured as a non-taxable contribution and exchange, with contributing entities conveying their interests in exchange for 915,694 common units representing limited partnership interests in Dorchester Minerals, L.P. [1]
Petrus Resources Declares Monthly Dividend for September 2025
Globenewswire· 2025-09-02 21:10
Core Points - Petrus Resources Ltd. has declared a monthly dividend of $0.01 per share, payable on September 29, 2025, to shareholders of record on September 15, 2025 [1] - The dividend is classified as an eligible dividend for Canadian income tax purposes [1] Dividend Reinvestment Plan (DRIP) - The DRIP allows eligible shareholders to reinvest all or part of their cash dividends into additional common shares at a 3% discount from the market price [2] - Participation in the DRIP is optional for shareholders [2] - Registered shareholders must submit an enrollment form to Odyssey Trust Company before 4:00 p.m. on the 5th business day prior to the dividend record date to participate [3] Company Overview - Petrus is a public Canadian oil and gas company focused on property exploitation, strategic acquisitions, and risk-managed exploration in Alberta [5]
Fairfax Announces Quarterly Dividend on Series G, H, I, J and K Preferred Shares and Quarterly Dividend Rate for Series J Preferred Shares
Globenewswire· 2025-09-02 21:02
Group 1 - Fairfax Financial Holdings Limited has declared quarterly dividends per share on its preferred shares, with specific amounts and payment dates outlined for Series G, H, I, J, and K [1] - The dividend amounts for Series G, H, I, J, and K are C$0.185125, C$0.32792, C$0.207938, C$0.34620, and C$0.315313 respectively, with payment dates on September 29 and 30, 2025 [1] - Applicable Canadian withholding tax will be applied to dividends payable to non-residents of Canada [1] Group 2 - Fairfax has determined the quarterly dividend rate for its floating rate preferred shares for the period from September 30, 2025, to December 30, 2025, with Series J having a rate of 1.38907% and an annualized rate of 5.51099% [2] - The dividend per share for Series J is set at C$0.34727 for the specified period [2] - Fairfax operates primarily in property and casualty insurance and reinsurance, along with associated investment management through its subsidiaries [2] Group 3 - Fairfax intends to redeem all outstanding Cumulative 5-Year Rate Reset Preferred Shares, Series G, and all outstanding Cumulative Floating Rate Preferred Shares, Series H, on September 30, 2025 [3]
Enlightify Inc. Receives Continued Listing Standards Notice from the New York Stock Exchange
Globenewswire· 2025-09-02 21:00
Core Points - Enlightify Inc. has been notified by the NYSE that its 30-trading-day average closing price per share is below $1.00, which is the minimum required for continued listing [1] - The company must notify the NYSE of its intent to cure the share price deficiency by September 11, 2025, and has six months to regain compliance [2] - The company's stock remains listed on the NYSE, and the notification does not impact its business operations or SEC reporting obligations [3] Company Overview - Enlightify Inc. produces and distributes humic acid-based compound fertilizers and other agricultural products through its subsidiaries, including Shaanxi TechTeam Jinong Humic Acid Product Co., Ltd. and Beijing Gufeng Chemical Products Co., Ltd. [4] - In 2023, the company began purchasing digital asset mining machines and established Antaeus Tech Inc. to mine bitcoins in Texas [4]
Rocky Shore Gold Closes First Tranche of Non-Brokered Private Placement
Globenewswire· 2025-09-02 21:00
Core Points - Rocky Shore Gold Ltd. has successfully closed the first tranche of a non-brokered private placement, raising gross proceeds of $697,500 [1] - The first tranche involved the issuance of 6,800,000 units at C$0.05 per unit and 7,150,000 flow-through shares at the same price [1] - The proceeds from the units will be allocated for general corporate purposes, while the funds from the flow-through shares will be directed towards the exploration of the Gold Anchor Project [3] Financial Details - Each unit consists of one common share and one-half of a common share purchase warrant, with the warrants exercisable at C$0.10 until September 2, 2028 [2] - The company issued an aggregate of 606,000 finder's warrants to eligible finders, each exercisable at $0.05 until March 2, 2027 [4] - All securities issued are subject to a statutory hold period expiring on January 3, 2026 [5] Company Overview - Rocky Shore Gold is focused on major gold discoveries at its 100%-owned Gold Anchor Project, located in central Newfoundland, which is recognized as a promising gold belt [6] - The Gold Anchor Project covers over 1,200 square kilometers and is strategically positioned near significant gold discoveries and deposits [6] - The project includes numerous gold-bearing faults, notably the Appleton and JBP Faults, enhancing its exploration potential [6]